|
⚲
|
| Keyboard |
| Sergio Traversa | |
|---|---|
| Firm | |
| Address | 650 NE 32nd Street, 3804 Miami, FL 33137 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Enzeta Immunotherapies Inc | 021-538757 | Director | 0.8 M of 2.4 M |
||
| Relmada Therapeutics Inc | 021-350641 | Executive Officer | 0.8 M of 0.8 M |
||
| Relmada Therapeutics Inc | 021-343016 | Executive Officer | 8.4 M of 10.0 M |
||
| Relmada Therapeutics Inc | 021-339798 | Executive Officer | 3.4 M of 10.0 M |
||
| Relmada Therapeutics Inc | 021-324029 | Executive Officer | 5.8 M of 10.0 M |
||
| Relmada Therapeutics Inc | 021-296142 | Executive Officer | 6.9 M of 6.9 M |
||
| Camp Nine Inc | 021-219502 | Executive Officer | 10.7 M of 10.7 M |
||
| Camp Nine Inc | 021-218540 | Executive Officer | |||
| Relmada Therapeutics Inc | 021-217828 | Executive Officer | 15.1 M of 15.1 M |
||
| Actinium Pharmaceuticals Inc | 021-209458 | Executive Officer | 6.6 M of 6.6 M |
||
| Actinium Pharmaceuticals Inc | 021-202314 | Executive Officer | |||
| Relmada Therapeutics Inc | 021-197621 | Executive Officer | 0.2 M of 0.8 M |
||
| Cactus Ventures Inc | 021-193542 | Executive Officer | |||
| Actinium Pharmaceuticals Inc | 021-189157 | Director | 5.1 M of 15.0 M |
||
| Relmada Therapeutics Inc | 021-181601 | Executive Officer | 5.0 M of 8.0 M |
||
| Ardana Healthcare Fund LP | 021-130594 | Executive Officer | 1.2 M | ||